United States
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
900.08 |
Jan. 14, 2025 | USD 91.00 | 1.18% |
|
United States |
|
2 |
816.19 |
Jan. 14, 2025 | USD 58.67 | -1.59% |
|
United States |
|
3 |
426.62 |
Jan. 14, 2025 | USD 71.93 | -0.61% |
|
United States |
|
4 |
365.27 |
Jan. 14, 2025 | USD 65.65 | -1.41% |
|
United States |
|
5 |
280.94 |
Jan. 14, 2025 | USD 252.89 | 2.41% |
|
United States |
|
6 |
279.56 |
Jan. 14, 2025 | USD 5.44 | 3.42% |
|
United States |
|
7 |
196.51 |
Jan. 14, 2025 | USD 21.00 | 1.25% |
|
United States |
|
8 |
154.14 |
Jan. 14, 2025 | USD 169.99 | -3.10% |
|
United States |
|
9 |
144.76 |
Jan. 14, 2025 | USD 30.62 | 0.39% |
|
United States |
|
10 |
131.21 |
Jan. 14, 2025 | USD 88.18 | 1.15% |
|
United States |
|
11 |
127.53 |
Jan. 14, 2025 | USD 14.93 | 5.36% |
|
United States |
|
12 |
122.19 |
Jan. 14, 2025 | USD 7.82 | 0.51% |
|
United States |
|
13 |
117.38 |
Jan. 14, 2025 | USD 25.46 | -2.64% |
|
United States |
|
14 |
113.14 |
Jan. 14, 2025 | USD 166.09 | 0.31% |
|
United States |
|
15 |
112.77 |
Jan. 14, 2025 | USD 7.87 | -0.51% |
|
United States |
|
16 |
100.73 |
Jan. 14, 2025 | USD 88.70 | -0.64% |
|
United States |
|
17 |
93.16 |
Jan. 14, 2025 | USD 118.83 | 0.34% |
|
United States |
|
18 |
92.85 |
Jan. 14, 2025 | USD 103.61 | 1.76% |
|
United States |
|
19 |
88.54 |
Jan. 14, 2025 | USD 148.22 | 1.40% |
|
United States |
|
20 |
85.57 |
Jan. 14, 2025 | USD 538.88 | -0.16% |
|
United States |
|
21 |
80.11 |
Jan. 14, 2025 | USD 12.48 | NA |
|
United States |
|
22 |
80.04 |
Jan. 14, 2025 | USD 744.91 | -6.59% |
|
United States |
|
23 |
78.80 |
Jan. 14, 2025 | USD 95.65 | 1.10% |
|
United States |
|
24 |
78.79 |
Jan. 14, 2025 | USD 74.73 | -2.21% |
|
United States |
|
25 |
78.33 |
Jan. 14, 2025 | USD 142.64 | -5.10% |
|
United States |
|
26 |
77.62 |
Jan. 14, 2025 | USD 25.62 | 11.39% |
|
United States |
|
27 |
77.11 |
Jan. 14, 2025 | USD 6.03 | -1.63% |
|
United States |
|
28 |
75.75 |
Jan. 14, 2025 | USD 16.69 | -2.46% |
|
United States |
|
29 |
70.71 |
Jan. 14, 2025 | USD 28.76 | -0.48% |
|
United States |
|
30 |
64.31 |
Jan. 14, 2025 | USD 62.54 | -2.36% |
|
United States |
|
31 |
60.57 |
Jan. 14, 2025 | USD 175.55 | -0.67% |
|
United States |
|
32 |
56.62 |
Jan. 14, 2025 | USD 16.32 | -1.03% |
|
United States |
|
33 |
56.55 |
Jan. 14, 2025 | USD 26.21 | 1.20% |
|
United States |
|
34 |
54.44 |
Jan. 14, 2025 | USD 50.77 | 2.13% |
|
United States |
|
35 |
53.03 |
Jan. 14, 2025 | USD 120.73 | -1.61% |
|
United States |
|
36 |
52.16 |
Jan. 14, 2025 | USD 95.85 | 1.78% |
|
United States |
|
37 |
51.09 |
Jan. 14, 2025 | USD 12.76 | -2.52% |
|
United States |
|
38 |
50.57 |
Jan. 14, 2025 | USD 7.66 | -1.42% |
|
United States |
|
39 |
48.56 |
Jan. 14, 2025 | USD 31.47 | 1.68% |
|
United States |
|
40 |
48.50 |
Jan. 14, 2025 | USD 99.89 | 4.44% |
|
United States |
|
41 |
47.75 |
Jan. 14, 2025 | USD 21.72 | -1.36% |
|
United States |
|
42 |
47.69 |
Jan. 14, 2025 | USD 328.96 | -3.13% |
|
United States |
|
43 |
46.34 |
Jan. 14, 2025 | USD 15.83 | 0.19% |
|
United States |
|
44 |
45.42 |
Jan. 14, 2025 | USD 79.17 | -0.84% |
|
United States |
|
45 |
45.33 |
Jan. 14, 2025 | USD 108.55 | 2.54% |
|
United States |
|
46 |
45.04 |
Jan. 14, 2025 | USD 234.50 | 0.17% |
|
United States |
|
47 |
44.50 |
Jan. 14, 2025 | USD 267.04 | -0.35% |
|
United States |
|
48 |
44.10 |
Jan. 14, 2025 | USD 237.62 | -0.94% |
|
United States |
|
49 |
43.05 |
Jan. 14, 2025 | USD 26.51 | 1.07% |
|
United States |
|
50 |
41.01 |
Jan. 14, 2025 | USD 138.83 | 2.72% |
|
United States |
The Health Care company in United States with the highest Price to Earnings Ratio (P/E) is Gilead Sciences, Inc. (NasdaqGS: GILD) at 900.08.
The Health Care company in United States with the lowest Price to Earnings Ratio (P/E) is Artivion, Inc. (NYSE: AORT) at -1,468.93.
The top 10 Health Care companies in United States by Price to Earnings Ratio (P/E) are Gilead Sciences, Inc., Vericel Corporation, Incyte Corporation, RadNet, Inc., Penumbra, Inc., ChromaDex Corporation, Privia Health Group, Inc., Inspire Medical Systems, Inc., Baxter International Inc. and Globus Medical, Inc..
The bottom 10 Health Care companies in United States by Price to Earnings Ratio (P/E) are Artivion, Inc., Indivior PLC, Repligen Corporation, Coherus BioSciences, Inc., Veracyte, Inc., Cross Country Healthcare, Inc., TG Therapeutics, Inc., Integra LifeSciences Holdings Corporation, Champions Oncology, Inc. and Vertex Pharmaceuticals Incorporated.